medigraphic.com
ISSN 1561-3062 (Electronic)

2022, Number 4

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2022; 48 (4)

Polycystic ovary syndrome in relatives of women with the syndrome

Ovies CG, Lardoeyt FR, Monteagudo PG

Language: Spanish
References: 25
Page:
PDF size: 499.57 Kb.


ABSTRACT

Introduction: Polycystic ovary syndrome is the endocrine disorder that most affects the reproductive sphere during a woman's fertile period. Its causes are not known exactly. Genetic factors intervene in polycystic ovary syndrome that have been observed in members of the same family with manifestations of the syndrome.
Objective: To determine the frequency of polycystic ovary syndrome in relatives of women who suffer from it to know and determine if there is a hereditary aggregation pattern.
Methods: An analytical case-control study was carried out in 25 women with polycystic ovary syndrome and 36 relatives, and 50 women without polycystic ovary syndrome and 65 relatives. They underwent a family tree, an interview that included family history, a physical examination and a gynecological ultrasound. Descriptive statistics were calculated, expressed as percentages. The chi-square test was used to compare proportions. A family aggregation study was carried out to determine the risk of suffering from the syndrome using 2x2 contingency tables with first-degree relatives, whether affected or not. The odds ratio was calculated as the magnitude of association.
Results: Polycystic ovary syndrome was diagnosed in 17 relatives of women with the syndrome and in 7 of the relatives of women without it. Having a mother with polycystic ovary syndrome increased the risk of suffering from it by six times and if she is a sister by 33 times.
Conclusions: Polycystic ovary syndrome is common in relatives of women with this diagnosis, but there is high risk of suffering from it if there is a relative who has it.


REFERENCES

  1. Acosta C. Patrón hormonal de mujeres con diagnóstico clínico y ecográfico del síndrome de ovarios poliquísticos. Rev Cubana Endocrinol. 2004 [acceso 05/12/2021];15(2):13-7. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532004000200003

  2. Strauss J. Some New Thoughts on the Pathophysiology and Genetics of Poly-cystic Ovary Syndrome. Ann NY Acad Sci. 2003 [acceso 05/12/2021];997:42-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14644808/

  3. Cooper H, Spellacy W, Prem K, Cohen W. Hereditary factors in the Stein Le-venthal syndrome. Am J Obstet Gynecol. 1968 [acceso 05/12/2021];100(3):371-87. Disponible en: https://www.semanticscholar.org/paper//fae9534f250d70a0602d2ec63ff667fe4a17924d

  4. Givens J. Ovarian hyperthecosis. N Engl J Med. 1971 [acceso 05/11/2021];285:691-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/5563490/

  5. Wilroy R, Givens J, Wiser W, Coleman S, Andersen R, Summitt R. Hyper-thecosis: an inheritable form of polycystic ovarian disease. Birth Defects Orig Artic. 1975 [acceso 05/11/2021];11(4):81-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/1156689/

  6. Ferriman D, Purdie A. The inheritance of polycystic ovarian disease and a pos-sible relationship to premature balding. Clin Endocrinol. 1979 [acceso 05/11/2021];11(3):291-300. Disponible en: https://pubmed.ncbi.nlm.nih.gov/509743/

  7. Govind A OM, Clayton RN. Policystic Ovaries Are Inherited as an Autosomal Dominant Trait: Analysis of 29 Polycystic Ovary Syndrome and 10 Control Families. J Clin Endocrinol Metab. 1999 [acceso 05/11/2021];84(1):38-43. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9920059/

  8. Hague WM, Adams J, Reeders ST, Peto TE, Jacobs HS. Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf). 1988 [acceso 05/11/2021];29(6):593-605. Disponible en: https://pubmed.ncbi.nlm.nih.gov/3076848/

  9. Lunde O, Magnus P, Sandvik L, Hoglo S. Familial clustering in the polycystic ovarian syndrome. GynecolObstet Invest. 1989 [acceso 05/11/2021];28(1):23-30. Disponible en: https://pubmed.ncbi.nlm.nih.gov/2777131/

  10. Unsal T, Konac E, Yesilkaya E, Yilmaz A, Bideci A, Ilke H, et al. Genetic polymorphisms of FSHR, CYP17, CYP1A, CAPN10, INSR, SERPINE1 genes in adoles-cent girls with polycystic ovary syndrome. J Assist Reprod Genet. 2009 [acceso 05/01/2021];26(4):205-16. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19387820/

  11. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011 [acceso 05/01/2021];43(1):55-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21151128/

  12. Shi, Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 2012 [acceso 05/01/2021];44(9):1020-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22885925/

  13. Hwang JY, Lee EJ, Jin Go M, Sung YA, Lee HJ, Heon Kwak S, et al. Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition. J. Hum. Genet. 2012 [acceso 07/01/2021];57(10):660-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22951595/

  14. Lee H, Oh J, Sung Y, Chung H, Kim H, Kim G, et al. Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome. Hum. Reprod. 2015 [acceso 05/01/2021];30(3):723-31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25574032/

  15. ESHRE/ASRM-Sponsored Pcwg. Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) 2004 Rotterdam. Hum Reprod. 2004 [acceso 10/12/2021];19(1):41-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14688154/

  16. Givens J. Familial polycystic ovarian hyperthecosis: a study of two families. Am J Obstet Gynecol. 1971 [acceso 10/12/2021];11:959-72. Disponible en: https://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1971&pages=959

  17. Givens J. Familial polycystic ovarian disease. Endocrinal Metab Clin North Am. 1988 [acceso 10/12/2021];17(4):771-83. Disponible en: https://pubmed.ncbi.nlm.nih.gov/3058473/

  18. Joe-Kechebelu N, Mbamara S, Kechebelu J. Familial trend in Polycystic Ovary Syndrome. Ann Afr Med. 2013 [acceso 10/12/2021];12(3):182-4. Disponible en: https://www.annalsafrmed.org/article.asp?issn=1596-3519;year=2013;volume=12;issue=3;spage=182;epage=184;aulast=Joe-kechebelu

  19. Torvinen A, Koivunen R, Pouta A, Franks S, Martikainen H, Bloigu A, et al. Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism. Gynecol Endocrinol. 2011 [acceso 10/12/2021];27(9):630-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20923278

  20. Shan D, Han J, Cai Y, Zou L, Xu L, Shen Y. Reproductive Health in First-degree Relatives of Patients with Polycystic Ovary Syndrome: A Review and Meta-analysis. J Clin Endocrinol Metab. 2022 [acceso 20/01/2022];107(1):273-95. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34453540/

  21. Kahsar-Miller MD, Nixon C, Boots LR. Prevalence of polycystic ovary syn-drome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001 [acceso 10/12/2021];75(1):53-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11163816/

  22. Legro R, Driscoll D, Strauss J, Dunaif A Evidence for a genetic basis for hyper-androgenemia in polycystic ovary syndrome. PNAS. 1998 [acceso 10/12/2021];95(25):1-9. Disponible en: https://www.pnas.org/doi/full/10.1073/pnas.95.25.14956

  23. Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndorme and relationhip with metabolic and inflamatory parameters. J Endocrinol Invest. 2017 [acceso 03/02/2021];340:487-97. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27838846/

  24. Jena D, Choudhory A, Mangaraj S, Sing M, Mohanty B, Baliarsimh K. Study of visceral and subcutaneos abdominal fat thickness and it correlation with cardiometabo lic rick factors and hormonal parameters in polycystic ovary syndrome. Indian J Endo-crinol Metab. 2018 [acceso 03/02/2021];22:321-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30090722/

  25. Osibogun O, Ogunmoroti O, Michos E. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020 [acceso 03/02/2021];30:399-404. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31519403/




2020     |     www.medigraphic.com